Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Non-cash Items: 2020-2024

Historic Non-cash Items for Therapeutics (RAPT) over the last 4 years, with Sep 2024 value amounting to $3,000.

  • Therapeutics' Non-cash Items fell 99.95% to $3,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $3,000, marking a year-over-year decrease of 99.95%. This contributed to the annual value of $23.2 million for FY2023, which is 146.22% up from last year.
  • Therapeutics' Non-cash Items amounted to $3,000 in Q3 2024, which was down 93.88% from $49,000 recorded in Q2 2024.
  • In the past 5 years, Therapeutics' Non-cash Items ranged from a high of $38.4 million in Q4 2021 and a low of $3,000 during Q3 2024.
  • In the last 3 years, Therapeutics' Non-cash Items had a median value of $8.0 million in 2023 and averaged $8.9 million.
  • As far as peak fluctuations go, Therapeutics' Non-cash Items skyrocketed by 245.38% in 2021, and later tumbled by 99.95% in 2024.
  • Over the past 5 years, Therapeutics' Non-cash Items (Quarterly) stood at $11.1 million in 2020, then soared by 245.38% to $38.4 million in 2021, then crashed by 75.47% to $9.4 million in 2022, then surged by 146.22% to $23.2 million in 2023, then plummeted by 99.95% to $3,000 in 2024.
  • Its Non-cash Items stands at $3,000 for Q3 2024, versus $49,000 for Q2 2024 and $1.3 million for Q1 2024.